Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Standard Biotools (LAB) Restructuring Costs (2022 - 2025)

Standard Biotools has reported Restructuring Costs over the past 5 years, most recently at -$10.5 million for Q4 2025.

  • Quarterly Restructuring Costs fell 456.85% to -$10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 92.27% year-over-year, with the annual reading at $2.2 million for FY2025, 92.27% down from the prior year.
  • Restructuring Costs was -$10.5 million for Q4 2025 at Standard Biotools, down from $9.4 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $17.2 million in Q1 2024 and troughed at -$10.5 million in Q4 2025.
  • The 4-year median for Restructuring Costs is $1.7 million (2025), against an average of $2.6 million.
  • Year-over-year, Restructuring Costs surged 1330.25% in 2024 and then plummeted 456.85% in 2025.
  • A 4-year view of Restructuring Costs shows it stood at -$1.2 million in 2022, then soared by 187.15% to $1.1 million in 2023, then surged by 172.35% to $3.0 million in 2024, then plummeted by 456.85% to -$10.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Restructuring Costs are -$10.5 million (Q4 2025), $9.4 million (Q3 2025), and $1.7 million (Q2 2025).